Ontimetrials08 Nov, 2021Business
ON-TIME Clinical Trial As a Foundation dedicated to increasing awareness of MDS worldwide and sharing information. The primary purpose of this study is to compare overall survival (OS) in patients receiving rigosertib plus best supportive care (BSC) to OS of patients receiving BSC in a population of patients with MDS with excess blasts having failed, being intolerant, or relapsing after Vidaza azacitidine or Dacogen decitabine treatment.
Xin88vnorg
Redefyne Moving & Storage
Cockfosters Flowers
Kqbd Site
Magic Movers Ottawa
Experorthopaedic Solutions
Richard Dush
Cellularport
Bhikhabhai Patel
Sunstar Paint Booths